Abstract
It has only been within the last few years that insights have been gained into the remarkable diversity of functions of the adenovirus early transcription region 4 (E4) products. The polypeptide encoded by E4 open reading frame 4 (E4orf4) has emerged as an enigmatic product. Although it accomplishes certain functions that propel viral replication, it has also been shown to be highly toxic, an effect that could dampen the infectious cycle, but that also might serve to facilitate release of viral progeny. When expressed alone, E4orf4 induces a novel form of p53-independent apoptosis in cancer cells but not in normal human cells, thus making it of potential use in cancer gene therapy. In addition, knowledge of its mechanism of action, especially with regard to its interaction with protein phosphatase 2A (PP2A), could provide insights to develop new small molecule anti-cancer drugs. Thus future studies on E4orf4 should be both informative and potentially valuable therapeutically. In this study we review the current status of knowledge on E4orf4.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Afifi R, Sharf R, Shtrichman R, Kleinberger T . 2001 J. Virol. 75: 4444–4447
Agostinis P, Derua R, Sarno S, Goris J, Merlevede W . 1992 Eur. J. Biochem. 205: 241–248
Boivin D, Morrison MR, Marcellus RC, Querido E, Branton PE . 1999 J. Virol. 73: 1245–1253
Bondesson M, Ohman K, Manervik M, Fan S, Akusjärvi G . 1996 J. Virol. 70: 3844–3851
Bondesson M, Svensson C, Linder S, Akusjarvi G . 1992 EMBO J. 11: 3347–3354
Bridge E, Medghalchi S, Ubol S, Leesong M, Ketner G . 1993 Virology 193: 794–801
Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini M . 2000 Oncogene 19: 1191–1195
Campbell KS, Auger KR, Hemmings BA, Roberts TM, Pallas DC . 1995 J. Virol. 69: 3721–3728
Chiou SK, White E . 1997 J. Virol. 71: 3515–3525
Cohen C, Schelling DL, Stark MJR . 1989 FEBS Lett. 250: 601–606
Colella S, Okgakil H, Ruediger R, Yang F, Nakamura M, Fujisawa H, Kleihues R, Walter G . 2001 Int. J. Cancer 93: 789–804
Costanzo MC, Hogan JD, Cusick ME, Davis BP, Fancher AM, Hodges PE, Kondu P, Lengieza C, Lew-Smith JE, Lingner C, Roberg-Perez KJ, Tillberg M, Brooks JE, Garrels JI . 2000 Nucleic Acids Res. 28: 73–76
Csortos C, Zolnierowicz S, Bako E, Durbin SD, DePaoli-Roach AA . 1996 J. Biol. Chem. 271: 2578–2588
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME . 1997 Cell 91: 231–241
de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW . 1998 Genes Dev. 12: 2434–2442
del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . 1997 Science 278: 687–689
Engel DA, Hardy S, Shenk T . 1988 Genes Dev. 2: 1517–1528
Estmer-Nilsson C, Petersen-Mahrt S, Durot C, Shtrichman R, Krainer AR, Kleinberger T, Akusjarvi G . 2001 EMBO J. 20: 864–871
Evangelista CCJ, Rodriguez Torres AM, Limbach MP, Zitomer RS . 1996 Genetics 142: 1083–1093
Evans DR, Hemmings BA . 2000 Mol. Gen. Genetics 264: 425–432
Evans DR, Stark MJ . 1997 Genetics 145: 227–241
Fernandes ER, Rooney RJ . 1997 Mol. Cell. Biol. 17: 1890–1903
Ferrigno P, Langan TA, Cohen P . 1993 Mol. Biol. Cell. 4: 669–677
Freyer GA, Katoh Y, Roberts RJ . 1984 Nucleic Acids Res. 12: 3503–3519
Frisch SM, Ruoslahti E . 1997 Curr. Opin. Cell. Biol. 9: 701–706
Frost JA, Alberts AS, Sontag E, Guan K, Mumby MC, Feramisco JR . 1994 Mol. Cell. Biol. 14: 6244–6252
Giancotti FG . 1997 Curr. Opin. Cell. Biol. 9: 691–700
Glenn GM, Eckhart W . 1995 J. Virol. 69: 3729–3736
Gross A, McDonnell JM, Korsmeyer SJ . 1999 Genes Dev. 13: 1899–1911
Groves MR, Hanlon N, Turowski P, Hemmings BA, Barford D . 1999 Cell 96: 99–110
Halbert DN, Cutt JR, Shenk T . 1985 J. Virol. 56: 250–257
Healy AM, Zolnierowicz S, Stapleton AE, Goebl M, DePaoli-Roach AA, Pringle JR . 1991 Mol. Cell. Biol. 11: 5767–5780
Hemmings BA . 1997a Science 275: 628–630
Hemmings BA . 1997b Science 277: 534
Hemmings BA, Adams-Pearson C, Maurer F, Muller P, Goris J, Merlevede W, Hofsteenge J, Stone SR . 1990 Biochemistry 29: 3166–3173
Hendrix P, Mayer-Jackel RE, Cron P, Goris J, Hofsteenge J, Merlevede W, Hemmings BA . 1993 J. Biol. Chem. 268: 15267–15276
Herisse J, Rigolet M, de Dinechin SD, Galibert F . 1981 Nucleic Acids Res. 9: 4023–4042
Janssens V, Goris J . 2001 Biochem. J. 353: 417–439
Kanopka A, Muhlemann O, Akusjarvi G . 1996 Nature 381: 535–538
Kanopka A, Mühlemann O, Petersen-Mahrt S, Estmer C, Ohrmalm C, Akusjärvi G . 1998 Nature 393: 185–187
Kaplan JM, Armentano D, Scaria A, Woodworth LA, Pennington SE, Wadsworth SC, Smith AE, Gregory RJ . 1999 J. Virol. 73: 4489–4492
Karin M, Hunter T . 1995 Curr. Biol. 5: 747–757
Khew-Goodall Y, Mayer RE, Maurer F, Stone SR, Hemmings BA . 1991 Biochemistry 30: 89–97
Kleinberger T . 2000 Apoptosis 5: 211–215
Kleinberger T, Shenk T . 1993 J. Virol. 67: 7556–7560
Korsmeyer SJ . 1999 Cancer Res. 59: 1693s–1700s
Kremmer E, Ohst K, Kiefer J, Brewis N, Walter G . 1997 Mol. Cell. Biol. 17: 1692–1701
Lavoie JN, Champagne C, Gingras MC, Robert A . 2000 J. Cell. Biol. 150: 1037–1056
Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC . 1998 J. Cell. Biol. 140: 637–645
Livne A, Shtrichman R, Kleinberger T . 2001 J. Virol. 75: 789–798
Mannervik M, Fan S, Ström AC, Helin K, Akusjärvi G . 1999 Virology 256: 313–321
Marcellus RC, Chan H, Paquette D, Thirwell S, Boivin D, Branton PE . 2000 J. Virol. 74: 7869–7877
Marcellus RC, Lavoie JN, Boivin D, Shore GC, Ketner G, Branton PE . 1998 J. Virol. 72: 7144–7153
Marcellus RC, Teodoro JG, Wu T, Brough DE, Ketner G, Shore GC, Branton PE . 1996 J. Virol. 70: 6207–6215
McCright B, Brothman AR, Virshup DM . 1996a Genomics 36: 168–170
McCright B, Rivers AM, Audlin S, Virshup DM . 1996b J. Biol. Chem. 271: 22081–22089
McCright B, Virshup DM . 1995 J. Biol. Chem. 270: 26123–26128
Mills JC, Stone NL, Pittman RN . 1999 J. Cell. Biol. 146: 703–708
Moreno CS, Park S, Nelson K, Ashby D, Hubalek F, Lane WS, Pallas DC . 2000 J. Biol. Chem. 275: 5257–5263
Müller U, Kleinberger T, Shenk T . 1992 J. Virol. 66: 5867–5878
Müller U, Roberts MP, Engel DA, Doerfler W, Shenk T . 1989 Genes Dev. 3: 1991–2002
Nagata S . 1997 Cell 88: 355–365
Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, Roberts TM . 1990 Cell 60: 167–176
Pallas DC, Weller W, Jaspers S, Miller TB, Lane WS, Roberts TM . 1992 J. Virol. 66: 886–893
Querido E, Teodoro JG, Branton PE . 1997 J. Virol. 71: 3526–3533
Ronne H, Carlberg M, Hu GZ, Nehlin JO . 1991 Mol. Cell. Biol. 11: 4876–4884
Roopchand DE, Lee JM, Shahinian S, Paquette D, Bussey H, Branton PE . 2001 Oncogene in press
Roulston A, Marcellus RC, Branton PE . 1999 Ann. Revs. Microbiol. 52: 577–628
Salvesen GS, Dixit VM . 1999 Proc. Natl. Acad. Sci. USA 96: 10964–10967
Scheidtmann KH, Mumby MC, Rundell K, Walter G . 1991 Mol. Cell. Biol. 11: 1996–2003
Shtrichman R, Kleinberger T . 1998 J. Virol. 72: 2975–2982
Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T . 1999 Proc. Natl. Acad. Sci. USA 96: 10080–10085
Shtrichman R, Sharf R, Kleinberger T . 2000 Oncogene 19: 3757–3765
Shu Y, Yang H, Hallberg E, Hallberg R . 1997 Mol. Cell. Biol. 17: 3242–3253
Sneddon AA, Cohen PT, Stark MJ . 1990 EMBO J. 9: 4339–4346
Sontag E, Fedorov S, Kamibayashi C, Robbins D, Cobb M, Mumby M . 1993 Cell 75: 887–897
Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC . 1995 J. Cell. Biol. 128: 1131–1144
Tanabe O, Nagase T, Murakami T, Nozaki H, Usui H, Nishito Y, Hayashi H, Kagamiyama H, Takeda M . 1996 FEBS Lett. 379: 107–111
Tehrani MA, Mumby MC, Kamibayashi C . 1996 J. Biol. Chem. 271: 5164–5170
Teodoro JG, Branton PE . 1997 J. Virol. 71: 1739–1746
Teodoro JG, Shore GC, Branton PE . 1995 Oncogene 11: 467–474
Turowski P, Myles T, Hemmings BA, Fernandez A, Lamb NJ . 1999 Mol. Biol. Cell. 10: 1997–2015
van Zyl W, Huang W, Sneddon AA, Stark M, Camier S, Werner M, Marck C, Sentenac A, Broach JR . 1992 Mol. Cell. Biol. 12: 4946–4959
Virtanen A, Gilardi P, Naslund A, LeMoullec JM, Pettersson U, Perricaudet M . 1984 J. Virol. 51: 822–831
Voorhoeve PM, Hijmans EM, Bernards R . 1999 Oncogene 18: 515–524
Walter G, Ruediger R, Slaughter C, Mumby M . 1990 Proc. Natl. Acad. Sci. USA 87: 2521–2525
Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J, Evans GA . 1998 Science 282: 284–287
Wang Y, Burke DJ . 1997 Mol. Cell. Biol. 17: 620–626
Wei H, Ashby DG, Moreno CS, Ogris E, Yeong FM, Corbett AH, Pallas DC . 2001 J. Biol. Chem. 276: 1570–1577
Whalen SG, Marcellus RC, Whalen A, Ahn NG, Ricciardi RP, Branton PE . 1997 J. Virol. 71: 3545–3553
Wu J, Tolstykh T, Lee J, Boyd K, Stock JB, Broach JR . 2000 EMBO J. 19: 5672–5681
Yamamoto K, Ichijo H, Korsmeyer SJ . 1999 Mol. Cell. Biol. 19: 8469–8478
Yan Z, Fedorov SA, Mumby MC, Williams RS . 2000 Mol. Cell. Biol. 20: 1021–1029
Yang H, Jiang W, Gentry M, Hallberg RL . 2000 Mol. Cell. Biol. 20: 8143–8156
Yang SI, Lickteig RL, Estes R, Rundell K, Walter G, Mumby MC . 1991 Mol. Cell. Biol. 11: 1988–1995
Zha H, Fisk HA, Yaffe MP, Mahajan N, Herman B, Reed JC . 1996 Mol. Cell. Biol. 16: 6494–6508
Zhao Y, Boguslawski G, Zitomer RS, DePaoli-Roach AA . 1997 J. Biol. Chem. 272: 8256–8262
Zolnierowicz S, Csortos C, Bondor J, Verin A, Mumby MC, DePaoli-Roach AA . 1994 Biochemistry 33: 11858–11867
Zolnierowicz S, V.H.C., Andjelkovic N, Cron P, Stevens I, Merlevede W, Goris J, Hemmings BA . 1996 Biochem. J. 317: 187–194
Acknowledgements
We thank Tamar Kleinberger for a critical reading of this manuscript. Work conducted on E4orf4 in our laboratory is supported by grants from the National Cancer Institute of Canada and from GeminX Biotechnologies Inc. DE Roopchand is supported by a Studentship from the Fonds FRSQ-FCAR-Santé du Québec.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Branton, P., Roopchand, D. The role of adenovirus E4orf4 protein in viral replication and cell killing. Oncogene 20, 7855–7865 (2001). https://doi.org/10.1038/sj.onc.1204862
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204862
Keywords
This article is cited by
-
Transcriptomic and proteomic analyses reveal new insights into the regulation of immune pathways during adenovirus type 2 infection
BMC Microbiology (2019)
-
Selective elimination of cancer cells by the adenovirus E4orf4 protein in a Drosophila cancer model: a new paradigm for cancer therapy
Cell Death & Disease (2019)
-
Arming oncolytic reovirus with GM-CSF gene to enhance immunity
Cancer Gene Therapy (2019)
-
Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene
Gene Therapy (2018)
-
Viral genes as oncolytic agents for cancer therapy
Cellular and Molecular Life Sciences (2015)